Samuel W. Boellner

1.5k citations

22 papers · 1.0k indexed · h-index 15

Psychiatry and Mental health top 2%
Cognitive Neuroscience top 5%
Pediatrics, Perinatology and Child Health top 5%
Cellular and Molecular Neuroscience top 10%
Clinical Psychology top 10%

Co-authors: Joseph Biederman Frank A. López Suma Krishnan Mark C. Chandler Ann Childress Craig Q. Earl Sharon B. Wigal James M. Swanson
Topics: Attention Deficit Hyperactivity Disorder (14 papers)Autism Spectrum Disorder Research (5 papers)Epilepsy research and treatment (4 papers)
Cited by: Psychiatry and Mental health Cognitive Neuroscience Cellular and Molecular Neuroscience
Journals: Neurology PEDIATRICS Biological Psychiatry
Partner nations: United States United Kingdom

In The Last Decade

Samuel W. Boellner

22 papers receiving 918 citations

Peers

Countries citing papers authored by Samuel W. Boellner

Since Specialization

Citations

This map shows the geographic impact of Samuel W. Boellner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel W. Boellner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel W. Boellner more than expected).

Fields of papers citing papers by Samuel W. Boellner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel W. Boellner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel W. Boellner. The network helps show where Samuel W. Boellner may publish in the future.

Co-authorship network of co-authors of Samuel W. Boellner

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel W. Boellner. A scholar is included among the top collaborators of Samuel W. Boellner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel W. Boellner. Samuel W. Boellner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: A single-dose, randomized, open-label, crossover study 2010 ·Clinical Therapeutics ·Samuel W. Boellner,Jeffrey G. Stark,Suma Krishnan,Yuxin Zhang	65
2	Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials 2009 ·Clinical Therapeutics ·Robert L. Findling,Sharon B. Wigal,Oscar G. Bukstein,Samuel W. Boellner,Howard Abikoff,John M. Turnbow,(unknown)	28
3	Varying the Wear Time of the Methylphenidate Transdermal System in Children With Attention-Deficit/Hyperactivity Disorder 2008 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Timothy E. Wilens,Samuel W. Boellner,Frank A. López,John M. Turnbow,Sharon B. Wigal,Ann Childress,Howard Abikoff,Michael J. Manos	47
4	Pharmacokinetics of a Guanfacine Extended‐Release Formulation in Children and Adolescents with Attention‐Deficit–Hyperactivity Disorder 2007 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Samuel W. Boellner,Michael Pennick,(unknown),A. G. Lyne,Amir Shojaei	48
5	Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study 2007 ·Biological Psychiatry ·Joseph Biederman,Samuel W. Boellner,Ann Childress,Frank A. López,Suma Krishnan,Yuxin Zhang	161
6	A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 2006 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Laurence L. Greenhill,Joseph Biederman,Samuel W. Boellner,Thomas A. Rugino,R. Bart Sangal,Craig Q. Earl,John Jiang,James M. Swanson	68
7	A Comparison of Once-Daily and Divided Doses of Modafinil in Children With Attention-Deficit/Hyperactivity Disorder 2006 ·The Journal of Clinical Psychiatry ·Joseph Biederman,James M. Swanson,Sharon B. Wigal,Samuel W. Boellner,Craig Q. Earl,Frank A. López,(unknown)	39
8	Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study 2006 ·Clinical Therapeutics ·Thomas Spencer,Howard Abikoff,Daniel F. Connor,Joseph Biederman,Steven R. Pliszka,Samuel W. Boellner,(unknown),Raymond Pratt	54
9	Improvements in Symptoms of Attention-Deficit/Hyperactivity Disorder in School-Aged Children with Lisdexamfetamine Dimesylate [LDX; NRP104] and Mixed Amphetamine Salts Extended-Release vs. Placebo 2006 ·Journal of Developmental & Behavioral Pediatrics ·Joseph Biederman,Samuel W. Boellner,Ann Childress,Frank A. López,Suma Krishnan,(unknown)	3
10	A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder 2006 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Laurence L. Greenhill,Joseph Biederman,Samuel W. Boellner,(unknown),(unknown),(unknown),(unknown),James M. Swanson	3
11	Efficacy and Safety of Modafinil Film–Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study 2005 ·PEDIATRICS ·Joseph Biederman,James M. Swanson,Sharon B. Wigal,Christopher J. Kratochvil,Samuel W. Boellner,Craig Q. Earl,John Jiang,Laurence L. Greenhill	98
12	P.6.018 Modafinil as therapy for ADHD in children: A 4-week, double-blind, placebo-controlled study 2004 ·European Neuropsychopharmacology ·Joseph Biederman,J. M. Swanson,Samuel W. Boellner,Frank A. López	2
13	Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1?5�years 2003 ·European Journal of Clinical Pharmacology ·Charles Oo,George Hill,Albert Dorr,Baolian Liu,Samuel W. Boellner,Penelope Ward	52
14	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of SLI381 (Adderall XR) in Children With Attention-Deficit/Hyperactivity Disorder 2002 ·PEDIATRICS ·Joseph Biederman,Frank A. López,Samuel W. Boellner,Mark C. Chandler	149
15	Single‐Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children 2001 ·The Journal of Clinical Pharmacology ·George M. Haig,Howard N. Bockbrader,David Wesche,Samuel W. Boellner,Danièle Ouellet,R. R. Brown,Edward J. Randinitis,Edward L. Posvar	58
16	Lack of a Clinically Significant Pharmacokinetic Drug Interaction Between Tiagabine and Valproate 1998 ·American Journal of Therapeutics ·Linda E. Gustavson,Kenneth W. Sommerville,Galen Witt,(unknown),G. Richard Granneman,Samuel W. Boellner	16
17	Lack of Pharmacokinetic Drug Interactions Between Tiagabine and Carbamazepine or Phenytoin 1998 ·American Journal of Therapeutics ·Linda E. Gustavson,Allen Cato,Samuel W. Boellner,Guoliang Cao,Jiang Qian,(unknown),Kenneth W. Sommerville	13
18	A single‐dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures 1997 ·Neurology ·Linda E. Gustavson,Samuel W. Boellner,G. Richard Granneman,Jiang Qian,(unknown),Tawakol A. El‐Shourbagy,Kenneth W. Sommerville	48
19	Congenital arteriovenous fistula of the vertebral artery and internal jugular vein 1972 ·The Journal of Pediatrics ·James Y. Suen,Samuel W. Boellner,C.A. Araoz,(unknown)	8
20	IMPAIRMENT OF INTESTINAL HYDROLYSIS OF LACTOSE IN NEWBORN INFANTS 1965 ·PEDIATRICS ·Samuel W. Boellner,Alice G. Beard,Theodore C. Panos,Ann H. Ross	29

About Samuel W. Boellner

Samuel W. Boellner is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Developmental and Educational Psychology, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include Attention Deficit Hyperactivity Disorder (14 papers), Autism Spectrum Disorder Research (5 papers) and Epilepsy research and treatment (4 papers). The work is most often cited by research in Psychiatry and Mental health (767 citations), Cognitive Neuroscience (290 citations) and Cellular and Molecular Neuroscience (214 citations). Samuel W. Boellner has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Joseph Biederman, Frank A. López, Suma Krishnan, Mark C. Chandler, Ann Childress, Craig Q. Earl, Sharon B. Wigal, James M. Swanson, Yuxin Zhang and John Jiang. Their work appears in journals such as Neurology, PEDIATRICS and Biological Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact